| |
|
|
BIOTOXTECH CO.,LTD. (086040) |
|
|
KOSDAQ |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
07.12 | 08.12 | 09.12 | 10.09 |
| Par Value |
500 | 500 | 500 | 500 |
| Yearly Highest Price |
9,080 | 4,425 | 6,230 | 4,940 |
| Yearly Lowest Price |
2,470 | 885 | 1,290 | 2,530 |
| Common Shares O/S |
7,917,351 | 7,917,351 | 8,845,260 | 8,845,759 |
| Preferred Shares O/S |
8,334 | 8,334 | 4,334 | 4,001 |
| Market Cap.(100Mn.Won) |
203 | 106 | 352 | 256 |
| Dividends (%) |
- | - | - | - |
|
 |
(Company/Sector/Market) |
| |
2009.06 | 2010.06 |
| Beta |
0.80 /- / 1.00 | 1.48 /- / 1.00 |
| Volatility |
84.85 /- / 43.15 | 75.43 /- / 19.11 |
|
 |
(unit : Won) |
| Fiscal Year End |
07.12 | 08.12 | 09.12 | 10.09 |
| Earnings Per Share |
27 | - 1,154 | 498 | - 44 |
| Sales Per Share |
1,171 | 1,265 | 1,954 | 2,023 |
| Book Value Per Share |
1,845 | 850 | 1,462 | 1,499 |
| Cash Flow Per Share |
- 60.56 | 215.78 | 653.68 | 271.32 |
|
 |
(Unit : Times) |
| Fiscal Year End |
07.12 | 08.12 | 09.12 | 10.09 |
| Price / Earnings (H/L) |
336.30/91.48 | -/- | 12.51/2.59 | -/- |
| Price / Sales (H/L) |
7.75/2.11 | 3.50/0.70 | 3.19/0.66 | 2.44/1.25 |
| Price / Book (H/L) |
4.92/1.34 | 5.21/1.04 | 4.26/0.88 | 3.29/1.69 |
| Price / Cash Flow (H/L) |
- /- | 20.51 / 4.10 | 9.53 / 1.97 | 18.21 / 9.32 |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
06.12 |
07.12 |
08.12 |
09.12 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
123 |
283 |
186 |
219 |
251 |
256 |
287 |
312 |
| NOPLAT |
14 |
45 |
0 |
45 |
- 74 |
48 |
44 |
92 |
| Return on Invested Capital |
11 |
16 |
0 |
20 |
- 29 |
18 |
15 |
29 |
| WACC |
5 |
7 |
4 |
7 |
5 |
7 |
6 |
7 |
| Economic Value Added |
8.0 |
25.6 |
- 8.5 |
28.5 |
- 87.0 |
28.5 |
25.6 |
70.4 |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2007.12 | 2008.12 | 2009.12 | 2010.09 |
| Enterprise Value(EV) |
254.62 | 310.12 | 521.44 | 374.16 |
| EBITDA |
21.72 | 10.43 | 50.57 | 39.37 |
| EBITDA/Sales |
0.22 | 0.10 | 0.31 | 0.22 |
| EBITDA/Financial Exp. |
6.41 | 1.99 | 5.37 | 3.31 |
| EV/EBITDA |
11.72 | 29.74 | 10.31 | 9.50 |
|
|
|
|
